Giuliana Cologni
Overview
Explore the profile of Giuliana Cologni including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
122
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pelusi S, Bianco C, Colombo M, Cologni G, Del Poggio P, Pugliese N, et al.
Liver Int
. 2023 Apr;
43(7):1593-1603.
PMID: 37035867
Background And Aims: Metabolic dysfunction (MD)-associated fatty liver disease has been proposed to identify individuals at risk of liver events irrespectively of the contemporary presence of other liver diseases. The...
2.
Valenti L, Pelusi S, Aghemo A, Gritti S, Pasulo L, Bianco C, et al.
Hepatol Commun
. 2021 Nov;
6(4):867-877.
PMID: 34811949
The aim of this study was to examine the impact of features of dysmetabolism on liver disease severity, evolution, and clinical outcomes in a real-life cohort of patients treated with...
3.
Soria A, Fava M, Bernasconi D, Lapadula G, Colella E, Valsecchi M, et al.
Liver Int
. 2020 Jan;
40(4):769-777.
PMID: 31970845
Background & Aims: In the direct-acting antiviral era, treatment of genotype-3 HCV (HCV-GT3) is still challenging. Real-life comparisons between recommended regimens, sofosbuvir (SOF)+daclatasvir (DAC), SOF/velpatasvir (VEL), glecaprevir/pibrentasvir (GLE/PIB), are scarce....
4.
Raffetti E, Donato F, Castelnuovo F, Ladisa N, Paraninfo G, Di Filippo E, et al.
J Transl Med
. 2015 Apr;
13:89.
PMID: 25886534
Background: The systemic inflammatory response has been postulated as having prognostic significance in a wide range of different cancer types. We aimed to assess the prognostic role of inflammatory markers...
5.
Motta D, Brianese N, Foca E, Nasta P, Maggiolo F, Fabbiani M, et al.
AIDS Res Ther
. 2012 Jun;
9(1):18.
PMID: 22703595
Background: The aim of this study was to explore the effects of HCV co-infection on virological effectiveness and on CD4+ T-cell recovery in patients with an early and sustained virological...
6.
Iannotti N, Masini G, Bernardini C, Soavi L, Cologni G, Malfatto E, et al.
J Antimicrob Chemother
. 2012 Jun;
67(10):2540-1.
PMID: 22678729
No abstract available.
7.
Maggiolo F, Callegaro A, Cologni G, Bernardini C, Velenti D, Gregis G, et al.
J Acquir Immune Defic Syndr
. 2012 Apr;
60(5):473-82.
PMID: 22481602
Background: Low-level viremia (LLV) is measurable, with enhanced assays, in many subjects with HIV RNA levels <50 copies per milliliter. The clinical consequences of LLV are unknown. Methods: In a...
8.
Torti C, dArminio-Monforte A, Pozniak A, Lapadula G, Cologni G, Antinori A, et al.
BMC Infect Dis
. 2011 Jan;
11:23.
PMID: 21266068
Background: Data regarding CD4+ recovery after switching from protease inhibitor (PI)-based regimens to regimens not containing PI are scarce. Methods: Subjects with virological success on first-PI-regimens who switched to NNRTI...
9.
Quiros-Roldan E, Calabresi A, Lapadula G, Tirelli V, Costarelli S, Cologni G, et al.
Antivir Ther
. 2008 Jun;
13(3):341-8.
PMID: 18572746
Background: The efficacy of long-term hepatitis B virus (HBV) treatment with tenofovir (TDF) in relation to lamivudine (LMV) resistance in HIV patients failing on LMV deserves further investigations. Methods: HIV-HBV...
10.
Nasta P, Gatti F, Puoti M, Cologni G, Bergamaschi V, Borghi F, et al.
AIDS
. 2008 Apr;
22(7):857-61.
PMID: 18427204
Objectives: To investigate the association between insulin resistance and rapid virologic response. Design: All consecutive HIV/hepatitis C virus coinfected patients who started peg-interferon alpha-2a (180 microg/week) and ribavirin 1000-1200 mg/day...